Sp568

PANEL DISCUSSION

Date
May 7, 2023
Explore related products in the following collection:

Society: AGA

Alcohol associated liver disease is still a very common entity. The session will provide a comprehensive approach to the aforementioned disease including clinical presentations, diagnosis and emerging treatments including liver transplant. LIVE STREAM SESSION

Presenters

Speaker Image for Craig McClain
University of Louisville
Speaker Image for Gyongyi Szabo
Beth Israel Deaconess Medical Center
Speaker Image for Nikolaos Pyrsopoulos
Rutgers The State University of New Jersey

Tracks

Related Products

Thumbnail for CURRENT AND EMERGING THERAPIES FOR ALCOHOL ASSOCIATED LIVER DISEASE
CURRENT AND EMERGING THERAPIES FOR ALCOHOL ASSOCIATED LIVER DISEASE
Alcohol associated liver disease is still a very common entity. The session will provide a comprehensive approach to the aforementioned disease including clinical presentations, diagnosis and emerging treatments including liver transplant…
Thumbnail for BENEFICIAL EFFECTS OF N-3 PUFA SUPPLEMENTATION ON LIVER INJURY, ENDOTOXEMIA, AND INFLAMMATION IN HEAVY DRINKING INDIVIDUALS
BENEFICIAL EFFECTS OF N-3 PUFA SUPPLEMENTATION ON LIVER INJURY, ENDOTOXEMIA, AND INFLAMMATION IN HEAVY DRINKING INDIVIDUALS
BACKGROUND: Alcohol-associated hepatitis (AH) is the active inflammatory state of alcohol-associated liver disease (ALD). AH varies in severity from mild to severe with mortality rates reaching 30-50% in severe AH…